Gainers
-
Immuron Limited (NASDAQ: IMRN) shares jumped 71.2
percent to $14.46 after the company disclosed positive results in NASH clinical trial.
-
PCM Inc (NASDAQ: PCMI) surged 39.5 percent to
$11.30 following Q4 results.
-
Net Element International Inc (NASDAQ: NETE)
shares rose 21.9 percent to $7.45. Net Element named Jon Najarian to its board.
-
Oragenics Inc (NASDAQ: OGEN) gained 20.2 percent
to $3.14 after surging 34.54 percent on Wednesday.
-
Comtech Telecomm. Corp. (NASDAQ: CMTL) shares
jumped 18.5 percent to $28.75 after reporting upbeat quarterly results.
-
Bravo Brio Restaurant Group, Inc. (NASDAQ: BBRG)
rose 15.4 percent to $4.00 after the company agreed to be acquired for $4.05 per share in cash.
-
Jounce Therapeutics Inc (NASDAQ: JNCE) climbed 15
percent to $25.12. Jounce Therapeutics reported a Q4 loss of $0.29 per share on sales of $13 million.
-
United Microelectronics Corp (ADR) (NYSE: UMC)
shares gained 11.6 percent to $2.70.
-
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX)
rose 11.5 percent to $8.05 following Q4 results.
-
Express Scripts Holding Company (NASDAQ: ESRX)
gained 11.1 percent to $81.54. CIGNA Corporation (NYSE: CI) announced plans to acquire Express Scripts for $67 billion.
-
Zosano Pharma Corp (NASDAQ: ZSAN) climbed 10.8
percent to $16.10 after gaining more than 55 percent Wednesday.
-
Orion Group Holdings Inc (NYSE: ORN) gained 10.4
percent to $6.99 following upbeat quarterly earnings.
-
Reis Inc (NASDAQ: REIS) rose 10.1 percent to
$21.90 as the company announced plans to explore strategic alternatives.
-
Anavex Life Sciences Corp. (NASDAQ: AVXL) climbed
9.4 percent to $3.16.
-
Discovery Communications Inc. (NASDAQ: DISCB)
shares rose 7.9 percent to $30.20.
-
Diplomat Pharmacy Inc (NYSE: DPLO) climbed 7.8
percent to $22.66. Barclays initiated coverage on Diplomat Pharmacy with an Overweight rating and a $27.00 price target.
-
Burlington Stores Inc (NYSE: BURL) gained 6.7
percent to $123.89 after the company reported upbeat earnings for its fourth quarter.
-
Innovate Biopharmaceuticals Inc (NASDAQ: INNT)
rose 6.5 percent to $13.84 after falling 10.34 percent on Wednesday.
-
Stage Stores Inc (NYSE: SSI) rose 6.3 percent to
$2.02. Stage Stores reported Q4 adjusted earnings of $0.45 per share on sales of $549 million.
-
Intellia Therapeutics Inc (NASDAQ: NTLA) gained 6
percent to $31.18. JMP Securities initiates coverage on Intellia Therapeutics with a Market Outperform rating and a $76.00
price target.
-
Genocea Biosciences Inc (NASDAQ: GNCA) rose 5.9
percent to $1.17. H.C. Wainwright initiated coverage on Genocea Biosciences with a Buy rating and a $5.00 price target.
-
International Game Technology (NYSE: IGT) gained 5.1
percent to $29.04 after the company reported Q4 results.
-
Wynn Resorts, Limited (NASDAQ: WYNN) rose 4.1
percent to $175.34 following news of dividend raise and QTD results from Vegas and Macau Properties.
-
Shiloh Industries, Inc. (NASDAQ: SHLO) shares
gained 3.7 percent to $8.41 following upbeat quarterly results.
Check out these big penny stock gainers and
losers
Losers
-
Vascular Biogenics Ltd (NASDAQ: VBLT) shares
dipped 61.4 percent to $2.62 after the company disclosed that its Phase 3 GLOBE study did not meet its pre-specified primary
endpoint of overall survival.
-
Volt Information Sciences, Inc. (NYSE: VISI) fell
36.4 percent to $2.45. Volt Info Sciences reported a Q1 loss of $0.51 per share on sales of $253.338 million.
-
FTD Companies Inc (NASDAQ: FTD) declined 35.1
percent to $4.38 after the company reported preliminary financial results for the full-year ended December 31, 2017 and updated
its 2018 business forecast.
-
tronc Inc (NASDAQ: TRNC) fell 22.6 percent to
$15.35 after reporting Q4 results.
-
Meet Group Inc (NASDAQ: MEET) fell 21.3 percent
to $2.51 after the company posted Q4 results.
-
Zagg Inc (NASDAQ: ZAGG) dipped 20.2 percent to
$12.38 after the company posted downbeat quarterly earnings.
-
Tech Data Corp (NASDAQ: TECD) fell 19.4 percent
to $86.78 after the company issued a weak forecast for the current quarter.
-
Myomo Inc (NYSE: MYO) fell 16.4 percent to $4.23.
Myomo reported a Q4 loss of $0.25 per share on sales of $547,000.
-
XOMA Corporation (NASDAQ: XOMA) dropped 16.1
percent to $23.96. XOMA reported a Q4 loss of $0.16 per share on sales of $5.357 million. The company also announced a $300
million mixed securities shelf offering.
-
Foundation Medicine Inc (NASDAQ: FMI) fell 12.9
percent to $72.51 following wider-than-expected Q4 loss.
-
BioScrip Inc (NASDAQ: BIOS) declined 12.5 percent
to $2.68 following Q4 results.
-
Viking Therapeutics Inc (NASDAQ: VKTX) fell 12.2
percent to $5.27. Viking Therapeutics reported a Q4 loss of $0.14 per share.
-
Kroger Co (NYSE: KR) fell 12.1 percent to $23.07.
Kroger posted in-line Q4 earnings.
-
Catasys, Inc. (NASDAQ: CATS) dropped 10.7 percent
to $4.76.
-
NN, Inc. (NASDAQ: NNBR) shares slipped 10.5
percent to $ 23.80 following downbeat quarterly earnings.
-
Checkpoint Therapeutics Inc (NASDAQ: CKPT) shares
fell 10.3 percent to $4.79 after the company reported a proposed public offering of common stock.
-
CIGNA Corporation (NYSE: CI) slipped 10 percent to
$174.79 as the company announced plans to acquire Express Scripts for $67 billion.
-
Fairmount Santrol Holdings Inc (NYSE: FMSA) shares
fell 8.6 percent to $4.11 following weak Q4 results.
-
ShiftPixy Inc (NASDAQ: PIXY) fell 8.4 percent to
$3.91 after gaining 66.15 percent on Wednesday.
-
CalAmp Corp. (NASDAQ: CAMP) dropped 6 percent to
$ 23.29. Craig-Hallum downgraded CalAmp from Buy to Hold.
-
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) fell 5
percent to $9.05 after reporting an offering of $50 million in common shares.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.